ArticleBMJ open2018
Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data.
Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 4 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Audiological Features in Patients with Rheumatoid Arthritis: A Systematic Review.International journal of molecular sciences · 2024Pooled it
- Sensorineural Hearing Loss in Autoimmune Diseases: A Systematic Review and Meta-analysis.The journal of international advanced otology · 2023Pooled it
- Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review.Frontiers in endocrinology · 2022Pooled it
- Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis.Rheumatology international · 2020Pooled it
- Sensorineural Hearing Loss in Major Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2026Review
- Hearing Loss in Connective Tissue Diseases: A Systematic Review.European journal of rheumatology · 2025Article
- A Case Report of Auditory and Vestibular Findings in a Patient with Rheumatoid Arthritis and Diabetes Mellitus.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024Article
- [Hearing impairment in the population over 55 years of age and its relationship with chronic diseases and perceived health].Revista espanola de salud publica · 2023Article
- Prevalence Rate of Hearing Loss in Patients with Rheumatoid Arthritis.Advanced biomedical research · 2023Article
- Hearing Function in Adults with Rheumatoid Arthritis: A Scoping Review for Preventive Audiology Planning.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022Article
- Increased risk of sudden sensory neural hearing loss in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort.Clinical rheumatology · 2019Article
- Hearing status in patients with rheumatoid arthritis.Caspian journal of internal medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPopulation studies on hearing loss (HL) associated with rheumatoid arthritis (RA) are lacking. This study investigated the risk of developing HL in patients with RA using a nationwide population cohort.
settingThe population-based insurance claims data in the Taiwan National Health Insurance Research Database.
designRetrospective cohort study followed up RA cohort and control cohort without RA frequency matched by sex, age and diagnosis year. STUDY POPULATION: 18 267 patients with RA newly diagnosed in 2000-2006 and 73 068 controls without RA. MAIN OUTCOMES: Incidences of HL by the end of 2011 and the RA cohort to non-RA cohort HRs after adjusting for sex, age and comorbidities.
resultsThe HL incidence was higher in the RA cohort than in the non-RA cohort (3.08 vs 1.62 per 1000 person-years), with an adjusted HR (aHR) of 1.91 (95% CI 1.70 to 2.14) for the RA cohort relative to the non-RA cohort after controlling for age, sex and comorbidities. Men and the elderly are at a higher risk. Cardiovascular comorbidities were associated with a further increased HL risk for patients with RA. Medications were associated with reduced HL incidence; patients with RA who used non-steroidal anti-inflammatory drugs (NSAIDs) had an aHR of 0.12 (95% CI 0.07 to 0.20), compared with non-users.
conclusionsThis study demonstrates that patients with RA are at an increased risk of developing HL. Findings highlight the need of disease-modifying treatment and scheduled auditory examinations for HL prevention and early detection for patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.